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Figure 5.32(D) Cyclic voltammogram of complex MnP-4-NH2BZO;  
Epa = anodic oxidation peak, Epc = cathodic reduction peak 
 
246 
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Figure 5.33 Cleavage of supercoiled pBR322 by complex MnP-4-Cl-2-NO2BZO at 
different concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA 
ladder; L2, DNA alone; L3, DNA + H2O2 alone; L4, DNA + complex alone 
(80 µM). Lanes 5-12 DNA with increasing concentration of complex MnP-4-
Cl-2-NO2BZO + H2O2: lane 5, 10 µM; lane 6, 20 µM; lane 7, 30 µM; lane 8, 
40 µM; lane 9, 50 µM; lane 10, 60 µM; lane 11, 70 µM; lane 12, 80 µM.  
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Figure 5.34 Cleavage of supercoiled pBR322 by complex MnP-3-NO2-5-NO2BZO at 
different concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA 
ladder; L2, DNA alone; L3, DNA + H2O2 alone; L4, DNA + complex alone 
(160 µM). Lanes 5-12 DNA with increasing concentration of complex MnP-
3-NO2-5-NO2BZO + H2O2: lane 5, 80 µM; lane 6, 100 µM; lane 7, 110 µM; 
lane 8, 120 µM; lane 9, 130 µM; lane 10, 140 µM; lane 11, 150 µM; lane 12, 
160 µM.   
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Figure 5.35 Cleavage of supercoiled pBR322 by complex Mn-4-NO2BZO at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4, DNA + complex alone (160 µM). 
Lanes 5-12 DNA with increasing concentration of complex Mn-4-NO2BZO 
+ H2O2: lane 5, 80 µM; lane 6, 100 µM; lane 7, 110 µM; lane 8, 120 µM; lane 
9, 130 µM; lane 10, 140 µM; lane 11, 150 µM; lane 12, 160 µM.   
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Figure 5.36 Cleavage of supercoiled pBR322 by complex MnP-4-NH2BZO at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4, DNA  + complex alone (160 µM). 
Lanes 5-12 DNA with increasing concentration of complex MnP-4-NH2BZO 
+ H2O2: lane 5, 80 µM; lane 6, 100 µM; lane 7, 110 µM; lane 8, 120 µM; lane 
9, 130 µM; lane 10, 140 µM; lane 11, 150 µM; lane 12, 160 µM. 
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Figure 5.37 Cleavage of supercoiled pBR322 by complex MnP-4-FBZO at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4 DNA + complex alone (80 µM). 
Lanes 5-12 DNA with increasing concentration of complex MnP-4-FBZO + 
H2O2: lane 5, 10 µM; lane 6, 20 µM; lane 7, 30 µM; lane 8, 40 µM; lane 9, 50 
µM; lane 10, 60 µM; lane 11, 70 µM; lane 12, 80 µM.   
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Figure 5.38 Cleavage of supercoiled pBR322 by complex MnP-4-ClBZO at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4 DNA + complex alone (80 µM). 
Lanes 5-12 DNA with increasing concentration of complex MnP-4-ClBZO + 
H2O2: lane 5, 10 µM; lane 6, 20 µM; lane 7, 30 µM; lane 8, 40 µM; lane 9, 50 
µM; lane 10, 60 µM; lane 11, 70 µM; lane 12, 80 µM.  
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Figure 5.39 Cleavage of supercoiled pBR322 by complex MnPGLY at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4, DNA + complex alone (80 µM). 
Lanes 5-12 DNA with increasing concentration of complex MnPGLY + 
H2O2: lane 5, 10 µM; lane 6, 20 µM; lane 7, 30 µM; lane 8, 40 µM; lane 9, 50 
µM; lane 10, 60 µM; lane 11, 70 µM; lane 12, 80 µM.   
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Figure 5.40 Cleavage of supercoiled pBR322 by complex MnPyr at different 
concentrations in TN buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, 
DNA alone; L3, DNA + H2O2 alone; L4, DNA + complex alone (80 µM). 
Lanes 5-12 DNA with increasing concentration of complex MnPyr + H2O2: 
lane 5, 10 µM; lane 6, 20 µM; lane 7, 30 µM; lane 8, 40 µM; lane 9, 50 µM; 
lane 10, 60 µM; lane 11, 70 µM; lane 12, 80 µM.   
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Figure 5.41 Cleavage of supercoiled pBR322 by MnCl2 at different concentrations in TN 
buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder; L2, DNA alone; L3, DNA + 
H2O2 alone; L4, DNA  + MnCl2 alone (160 µM); lane 5, 80 µM; lane 6, 100 
µM; lane 7, 110 µM; lane 8, 120 µM; lane 9, 130 µM; lane 10, 140 µM; lane 
11, 150 µM; lane 12, 160 µM 
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Figure 5.42 Effect of various scavengers on the cleavage of pBR322 by 50 µM complex 
MnP-4-Cl-2-NO2BZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA 
alone; lane 3, DNA + 50 µM complex MnP-4-Cl-2-NO2BZO + H2O2.  Lanes 
4 – 12 involves reaction of 50 µM complex MnP-4-Cl-2-NO2BZO + H2O2 
with DNA in presence of various scavengers; lane 4, t-butyl alcohol (1 M); 
lane 5, 1 mM Mannitol; lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 
mM NaN3; lane 9, 20 mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM 
NaN3; lane 12, 100 mM NaN3.  
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Figure 5.43 Effect of various scavengers on the cleavage of pBR322 by 100 µM complex 
MnP-3-NO2-5-NO2BZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA 
alone; lane 3, DNA + 100 µM complex MnP-3-NO2-5-NO2BZO + H2O2.  
Lanes 4 – 12 involves reaction of 100 µM complex MnP-3-NO2-5-NO2BZO 
+ H2O2 with DNA in presence of various scavengers; lane 4, t-butyl alcohol 
(1 M); lane 5, 1 mM Mannitol; lane 6, DMSO (1 M); lane 7, 1 mM NaN3; 
lane 8, 10 mM NaN3; lane 9, 20 mM NaN3; lane 10, 30 mM NaN3; lane 11, 
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Figure 5.44 Effect of various scavengers on the cleavage of pBR322 by 110 µM complex 
Mn-4-NO2BZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; 
lane 3, DNA + 110 µM complex Mn-4-NO2BZO + H2O2.  Lanes 4 – 12 
involves reaction of 110 µM complex Mn-4-NO2BZO + H2O2 with DNA in 
presence of various scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM 
Mannitol; lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; 
lane 9, 20 mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 
100 mM NaN3.  
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Figure 5.45 Effect of various scavengers on the cleavage of pBR322 by 100 µM complex 
MnP-4-NH2BZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; 
lane 3, DNA + 100 µM complex MnP-4-NH2BZO + H2O2.  Lanes 4 – 12 
involves reaction of 100 µM complex MnP-4-NH2BZO + H2O2 with DNA in 
presence of various scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM 
Mannitol; lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; 
lane 9, 20 mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 
100 mM NaN3. 
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Figure 5.46 Effect of various scavengers on the cleavage of pBR322 by 50 µM complex 
MnP-4-FBZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; 
lane 3, DNA + 50 µM complex MnP-4-FBZO + H2O2.  Lanes 4 – 12 involves 
reaction of 50 µM complex MnP-4-FBZO + H2O2 with DNA in presence of 
various scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; 
lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; lane 9, 20 
mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 100 mM 
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Figure 5.47 Effect of various scavengers on the cleavage of pBR322 by 60 µM complex 
MnP-4-ClBZO. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; 
lane 3, DNA + 60 µM complex MnP-4-ClBZO + H2O2.  Lanes 4 – 12 
involves reaction of 60 µM complex MnP-4-ClBZO + H2O2 with DNA in 
presence of various scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM 
Mannitol; lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; 
lane 9, 20 mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 
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Figure 5.48 Effect of various scavengers on the cleavage of pBR322 by 60 µM complex 
MnPGLY. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; lane 3, 
DNA + 60 µM complex MnPGLY + H2O2. Lanes 4 – 12 involves reaction of 
60 µM complex MnPGLY + H2O2 with DNA in presence of various 
scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; lane 6, 
DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; lane 9, 20 mM 
NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 100 mM NaN3.  
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Figure 5.49  Effect of various scavengers on the cleavage of pBR322 by 60 µM complex 
MnPyr. Lane 1, Gene Ruler 1 kb DNA ladder; lane 2, DNA alone; lane 3, 
DNA + 60 µM complex MnPyr + H2O2.  Lanes 4 – 12 involves reaction of 60 
µM complex MnPyr + H2O2 with DNA in presence of various scavengers; 
lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; lane 6, DMSO (1 M); 
lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; lane 9, 20 mM NaN3; lane 10, 30 
mM NaN3; lane 11, 50 mM NaN3; lane 12, 100 mM NaN3.  
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L2 DNA alone, L3 H2O2 alone, L4 complex VOPhen alone (40 µM). Lanes 
5-12 DNA with increasing concentration of complex VOPhen + H2O2: lane 
5, 5 µM; lane 6, 10 µM; lane 7, 15 µM; lane 8, 20 µM; lane 9, 25 µM; lane 
10, 30 µM; lane 11, 35 µM; lane 12, 40 µM.  
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Figure 6.20 Cleavage of supercoiled pBR322 by complex VOPhen at different 
concentrations in Tris-HCl buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder, 
L2 DNA alone, Lanes 3-12 DNA with increasing concentration of complex 
VOPhen: lane 3, 50 µM; lane 4, 70 µM; lane 5, 100 µM; lane 6, 120 µM; 
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L2 DNA alone, L3 H2O2 alone, L4 complex VODMPhen alone (240 µM). 
Lanes 5-12 DNA with increasing concentration of complex VODMPhen + 
H2O2: lane 5, 100 µM; lane 6, 120 µM; lane 7, 140 µM; lane 8, 160 µM; lane 
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Figure 6.22 Cleavage of supercoiled pBR322 by complex VODPPhen at different 
concentrations in Tris-HCl buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder, 
L2 DNA alone, L3 H2O2 alone, L4 complex VODPPhen alone (40 µM). 
Lanes 5-12 DNA with increasing concentration of complex VODPPhen + 
H2O2: lane 5,  5 µM; lane 6, 10 µM; lane 7, 15 µM; lane 8, 20 µM; lane 9, 25 
µM; lane 10, 30 µM; lane 11, 35 µM; lane 12, 40 µM.  
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concentrations in Tris-HCl buffer pH 7.5. L1 Gene Ruler 1 kb DNA ladder, 
L2 DNA alone, L3 H2O2 alone, L4 complex VODMPPhen alone (240 µM). 
Lanes 5-12 DNA with increasing concentration of complex VODMPPhen + 
H2O2: lane 5, 100 µM; lane 6, 120 µM; lane 7, 140 µM; lane 8, 160 µM; lane 
9, 180 µM; lane 10, 200 µM; lane 11, 220 µM; lane 12, 240 µM.   
 
296 
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DNA + 25 µM complex VOPhen + H2O2.  Lanes 4 – 12 involves reaction of 
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scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; lane 6, 
DMSO (1 M); lane 7, 1 mM NaN3; lane 8,  10 mM NaN3;  lane 9,  20 mM 
NaN3;  lane 10,  30 mM NaN3;  lane 11,  50 mM NaN3;  lane 12,  100 mM 
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Figure 6.25 Effect of various scavengers on the cleavage of pBR322 by 120 µM complex 
VODMPhen. Lane 1, Gene Ruler 1 kb DNA ladder; Lane 2, DNA alone; 
Lane 3, DNA +120 µM complex VODMPhen + H2O2. Lanes 4 – 12 involves 
reaction of 120 µM complex VODMPhen + H2O2 with DNA in presence of 
various scavengers; lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; 
lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8, 10 mM NaN3; lane 9, 20 
mM NaN3; lane 10, 30 mM NaN3; lane 11, 50 mM NaN3; lane 12, 100 mM 
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Figure 6.26 Effect of various scavengers on the cleavage of pBR322 by 25 µM complex 
VODPPhen. Lane 1, Gene Ruler 1 kb DNA ladder; Lane 2, DNA alone; 
Lane 3, DNA + 25 µM complex VODPPhen + H2O2. Lanes 4 – 12 involves 
reaction of 25 µM complex VODPPhen + H2O2 with DNA in presence of 
various scavengers;  lane 4, t-butyl alcohol (1 M); lane 5, 1 mM Mannitol; 
lane 6, DMSO (1 M); lane 7, 1 mM NaN3; lane 8,  10 mM NaN3;  lane 9,  20 
mM NaN3;  lane 10,  30 mM NaN3;  lane 11,  50 mM NaN3;  lane 12,  100 
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VODMPPhen. Lane 1, Gene Ruler 1 kb DNA ladder; Lane 2, DNA alone; 
Lane 3, DNA +120 µM complex VODMPPhen + H2O2..  Lanes 4 – 12 
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SINTESIS, PENCIRIAN, SIFAT-SIFAT NUCLEOLITIK, 
ANTIBAKTERIA DAN 
ANTIPOLIFERATIF BAGI KOMPLEKS VANADIUM, KUPRUM 
DAN MANGAN 
 
                                                      Abstrak 
 
 
Siri kompleks bagi vanadium karboksilato, kuprum karboksilato, mangan karboksilato 
dan terbitan vanadium fenantrolina telah disintesis dan dicirikan. Maklumat penuh 
tentang kompleks ditunjukkan dalam Jadual 2.2 (muka surat 37). Kompleks ini telah 
dicirikan dengan menggunakan kristalografi X-ray, analisis unsur, FT-IR, spektroskopi 
UV–Vis dan siklik voltammetrik. Dalam kajian elektrokimia, kompleks vanadium 
karboksilato telah menunjukkan aktif redok dengan mempamerkan pasangan redok 
kuasi-berbalik yang selaras dengan VV/VIV proses redok, manakala kompleks kuprum 
karboksilato telah menunjukkan aktif redok dengan mempamerkan dua pasangan redok 
kuasi-berbalik yang selaras dengan CuIICuII/CuIICuI dan CuIICuI/CuICuI proses redok 
dan mangan karboksilato telah menunjukkan aktif redok dengan mempamerkan 
pasangan redok kuasi-berbalik yang selaras dengan MnII/MnIII proses redok. Dalam 
kajian nukleolitik, semua kompleks didapati boleh mengakibatkan pengoksidaan belahan 
DNA tetapi dengan cara yang berbeza. Kompleks kuprum karboksilato dan mangan 
karboksilato boleh mengakibatkan belahan DNA dalam kehadiran H2O2. Sementara itu,  
untuk kompleks vanadium karboksilato, kompleks vanadium(V) karboksilato 
memerlukan H2O2 untuk mengakibatkan belahan DNA manakala kompleks 
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vanadium(IV) karboksilato tidak memerlukan H2O2 untuk mengakibatkan belahan DNA. 
Bagi kompleks terbitan vanadium fenantrolina pula, mereka boleh mengakibatkan 
belahan DNA dalam kehadiran H2O2 dan dalam keadaan tanpa H2O2. 
Walaubagaimanapun, aktiviti belahan DNA meningkat secara mendadak dalam 
kehadiran H2O2. Agen perencet reaktif spesis oksigen (ROS) juga telah digunakan untuk 
menentukan spesis reaktif yang bertanggunjawab dalam belahan DNA. Hidroksil radikal 
dan oksigen tunggal adalah ROS yang bertanggunjawab dalam belahan DNA. Dalam 
penyaringan antibakteria, semua kompleks kecuali kompleks mangan karboksilato 
mempamerkan aktiviti antibakteria terhadap spesis bakteria Gram positif atau Gram 
negatif. Kompleks kuprum karboksilato menunjukkan aktiviti antibakteria yang sangat 
selektif di mana mereka hanya menunjukkan aktiviti antibakteria terhadap Enterobacter 
aerogenes berGram negatif bakteria. Aktiviti antibakteria kompleks terbitan vanadium 
fenantrolina telah menunjukan bahawa kumpulan metil yang terikat pada kedudukan 2 
dan 9 pada gelang fenantrolina dapat meningkatkan aktiviti antibakteria. Dalam 
penyaringan antipoliferatif, secara umum kompleks vanadium karboksilato 
mempamerkan aktiviti antipoliferatif yang lebih tinggi berbanding dengan kompleks 
kuprum karboksilato dan mangan karboksilato. Kompleks kuprum karboksilato dan 
mangan karboksilato menunjukkan selektiviti sitotoksik terhadap garisan sel kanser  
HepG2 apabila dibandingkan dengan garisan sel kanser MCF-7 dan Hela. Eksperimen 
nukleolitik telah menyarankan bahawa belahan atau fragmentasi DNA oleh ROS yang 
dihasilkan oleh kompleks berkemungkinan besar bertangungjawab terhadap aktiviti 
antipoliferatif yang dipamerkan oleh kompleks.  
 
 xlvii 
Synthesis, Characterization, Nucleolytic, Antibacterial and 
Antiproliferative Properties of Vanadium, Copper and Manganese 
Complexes 
 
ABSTRACT 
 
 
Series of vanadium carboxylato complexes, copper carboxylato complexes, manganese 
carboxylato complexes and vanadium phenanthroline derivative complexes have been 
synthesized and characterized. The details of all the complexes are tabulated in Table 2.2 
(page 37). The complexes have been characterized by X-ray crystallography, elemental 
analysis, FT-IR, UV–Vis spectroscopy and cyclic voltammetry. In electrochemistry 
studies, vanadium carboxylato complexes show redox active by displaying a quasi-
reversible redox couple corresponding to VV/VIV redox process while copper 
carboxylato complexes show redox active by displaying two quasi-reversible redox 
couples corresponding to CuIICuII/CuIICuI and CuIICuI/CuICuI redox processes and 
manganese carboxylato complexes show redox active by displaying a quasi-reversible 
redox couple corresponding to MnII/MnIII redox process. In nucleolytic studies, all the 
complexes can induce oxidative DNA cleavage but in different manner. The copper 
carboxylato complexes and manganese carboxylato complexes can induce DNA 
cleavage in the presence of H2O2. Meanwhile for vanadium carboxylato complexes, 
vanadium(V) carboxylato complexes require H2O2 to induce DNA cleavage while 
vanadium(IV) carboxylato complexes do not require H2O2 to induce DNA cleavage. As 
for vanadium phenanthroline derivative complexes, they can induce DNA cleavage in 
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the presence and in the absence of H2O2. However, the DNA cleavage activity of the 
vanadium phenanthroline derivative complexes is greatly enhanced in the presence of 
H2O2.  Reactive oxygen species (ROS) scavengers have also been used to ascertain the 
reactive species responsible for DNA cleavage. The hydroxyl radical and singlet oxygen 
species have been found to be the ROS that are responsible in the DNA cleavage 
reaction. In the antibacterial screening, all the complexes except manganese carboxylato 
complexes exhibit antibacterial activity against certain Gram negative or Gram positive 
bacteria species. Copper carboxylato complexes show a very selective antibacterial 
activity whereby they only exhibit antibacterial activity against Gram negative bacteria 
Enterobacter aerogenes. The antibacterial activity of vanadium phenanthroline derivative 
complexes reveals that methyl groups attached at the position 2 and 9 in phenanthroline 
ring may increase the complexes antibacterial activity. In antiproliferative screening, 
vanadium carboxylato complexes in general exhibit higher antiproliferative activity 
when compared to copper carboxylato complexes and manganese carboxylato 
complexes. Copper carboxylato complexes and manganese carboxylato complexes 
exhibit cytotoxic selectivity against HepG2 cancer cell line when compared to MCF-7 
and Hela cancer cell lines. The nucleolytic experiments suggest that the cleavage or 
fragmentation of DNA by ROS generated by the complexes maybe responsible for the 
antiproliferative activity exhibited by the complexes.  
 
Keywords: Vanadium Complexes; Copper Complexes; Manganese Complexes; DNA    
                    Cleavage; Antibacterial; Antiproliferative
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Biological roles and medicinal applications of metal complexes and metal ions 
 
Studies on biological activities of metal complexes have been one of our long-term 
interests. Metal complexes are well known to exhibit antibacterial, antiproliferative, 
antiapoptotic, anti-inflammatory and insulin mimetic properties [1-28]. Several of the 
metal complexes have entered clinical trials and few have been registered for clinical use 
[29-31]. Platinum based complexes such as cisplatin, carboplatin and oxaliplatin are 
widely used as chemotherapeutic agents against ovarian, lung, head, neck and colorectal 
cancers, and have greatly improving the survival rates of patients worldwide. Schematic 
structures of cisplatin, carboplatin and oxaliplatin are depicted in Figure 1.1. These 
platinum complexes react in vivo, crosslink the DNA in several different ways and 
subsequently interfering the cell division by mitosis. The damaged DNA elicits DNA  
repair mechanisms, which in turn activate apoptosis when repair proves impossible. 
Meanwhile, Aurum(I) thiolate drugs such as aurothiomalate (MyocrisinR), 
aurothioglucose (SolganolR), aurothiopropanol sulfonate (AllochrysinR), and the oral 
drug auranofin (RidauraR), are widely used for the treatment of difficult cases of 
rheumatoid arthritis. Bismuth(III) compounds such as bismuth subcitrate and 
subsalicylate are widely used for the treatment of diarrhoea, dyspepsia and gastric and 
duodenal ulcers. Bismuth(III) compounds are found to be antibacterial active against 
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bacteria Helicobacter pylori which is associated with the mucus layer of ulcers. Sodium 
nitroprusside (Na2[Fe
II(CN)5(NO)]·2H2O or (Nipride
R) is used to treat hypotensive while 
Cu-salicylate (AlcusalR) is used to treat inflammatory. The success of metal complexes 
in medicinal applications has aroused great interest in the development of new metal 
complexes to diagnose and treat diseases including cancers, bacteria and virus infection 
related diseases, inflammatory and diabetes.  
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Figure 1.1: Schematic structures of cisplatin, carboplatin and oxaliplatin 
 
Apart from metal complexes, metal ion or inorganic elements play essential roles in 
biological and biomedical processes in human health and disease as metalloenzymes and 
metalloproteins [29]. As metalloproteins, metal ions perform as catalyst or stabilizer to 
stabilize the protein tertiary or quaternary structure. In addition, many proteins need to 
bind one or more metal ions to perform their functions. Complex zinc ion is one of the 
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most important components of metalloproteins in the human body, which functions as 
DNA transcription and regulation as well as oxidation and hydrolysis, cleavage of 
peptide bonds as well as formation of phosphodiester bonds. Meanwhile, copper ion is 
presence in some of the most important metalloenzymes in the human body and 
functions as superoxide dismutase to neutralize free radical generated from various 
human biological systems. Metal ions are also very important for the structure and 
function (in the case of RNA) of nucleic acids.  Besides, many organic compounds used 
in medicine do not have a purely organic mode of action; some are activated or 
biotransformed by metal ions including metalloenzymes, others have a direct or indirect 
effect on metal ion metabolism. Some of the metal ions have also been registered for 
clinical used as therapy and diagnosis agents, as listed in Table 1.1. 
 
        Table 1.1: Some of metal ions in clinical use 
 
Compounds 
 
Function/Treat  
Li2CO3 
 
Prophylaxis for bipolar disorders 
CaCO3, Mg(OH)2 
 
Antacid 
La2
III(CO3)3 Chronic renal failure 
 
MgSO4 
 
Hypomagnesemia 
Potassium citrate 
 
Kidney stones 
Magnesium citrate 
 
Saline laxative 
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1.2 Antibacterial and antiproliferative activities of transition metal complexes 
 
Transition metal complexes such as vanadium, copper and manganese complexes are 
known to exhibit excellent antibacterial and antiproliferative activities. The summary of 
antibacterial and antiproliferative activities of selected few vanadium, copper and 
manganese complexes that have already described in the literatures is tabulated in Table 
1.2. Referring to Table 1.2, it can be seen that transition metal complexes are rich in 
antibacterial and antiproliferative activities, being active against a wide spectrum of 
bacteria species or cancer cells. Transition metal complexes may induce cell death 
through disruption of the cell cycle or by DNA strand scission [32]. There are evidences 
to indicate that metal complexes can induce DNA strand scission not directly reacting 
with DNA components but acting mainly through the production of highly reactive 
oxygen species, especially hydroxyl radicals generated in cells. These reactive oxygen 
species actually cause the DNA strand scission. Transition metal complexes through 
Fenton-like reactions and/or during the intracellular reduction can generate reactive 
oxygen species. Besides, some transition metal complexes, which are photoactivatable, 
can induce DNA cleavage upon UV irradiation and singlet oxygen is the common 
reactive oxygen species that is generated in this process. Rich diversity of antibacterial 
and antiproliferative activities by transition metal complexes provides exciting prospects 
for the design of novel therapeutic agents with unique mechanisms of action to act 
against certain bacteria or cancers, as different metal complexes can produce different 
therapeutic effect. Therefore, detailed investigations could be helpful in designing more 
potent antibacterial and anticancer agents for the therapeutic use. 
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Table 1.2: The antibacterial and antiproliferative activities of some vanadium, copper  
                  and manganese complexes 
 
Complexes Antibacterial/ 
Antiproliferative 
activity 
 
Bacteria 
species/Cancer cells 
Ref: 
[CuII(4-(2-pyridylmethyl)-1,7-
dimethyl-1,4,7-triazonane-2,6- 
dione)(CH3CN)2](ClO4)2 
Antibacterial 
 
 
 
 
 
 
Escherichia coli 
(T7), 
Staphylococus 
aureus,  
Pseudomonas 
aeruginosa 
13 
CuII(2-furancarbaldehyde 
thiosemicarbazone) 0.5H2O 
 
 
Antibacterial 
 
Bacillus subtilis,  
Staphylococus 
aureus 
18 
[Cu2
II(N,N’-bis(3-
aminopropyl)oxamide)( 2,2’-
bipyridine)( 2,4,6-
trinitrophenol)(H2O)]( 2,4,6-
trinitrophenol) 
 
Antibacterial 
 
Escherichia coli, 
Bacillus subtilis,  
Staphylococus 
aureus 
16 
CuII2(N,N’-bis(N-
hydroxyethylaminoethyl) 
oxamide)(2,4,6-trinitrophenol)2 
 
Antiproliferative 
 
SMMC-7721 human 
hepatocellular 
carcinoma cells, 
A549 human lung 
adenocarcinoma 
cells 
 
8 
CuII (ethyl 2-bis(2-
pyridylmethyl)aminopropionate)Cl2 
 
Antiproliferative 
 
Eca-109 human 
esophageal cancer 
cells, A549 human 
lung adenocarcinoma 
cells  
 
10 
CuII (norfloxacinato)(2,2’-
bipyridine)Cl2 
 
 
Antiproliferative 
 
HL-60 and K562 
human leukemia 
cells 
19 
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Table 1.2: Continued  
 
Complexes Antibacterial/ 
Antiproliferative 
activity 
 
Bacteria 
species/Cancer cells 
Ref: 
MnII(tetraphenyl porphyrin), 
(ebselen–porphyrin conjugate)  
Antibacterial 
 
Staphylococus 
aureus 
 
15 
MnII(tetraamide macrocyclic)NO3 Antibacterial Pseudomonas 
cepacicola, Klebsella 
aerogenous 
 
25 
MnII(6,7-dicycanodipyrido[2,2-
d:29,39-f ]quinoxaline) 
(NO3)(H2O)]NO3.CH3OH 
 
 
Antiproliferative 
 
BGC-823 human 
stomach cancer cells, 
HL-60 human 
leukemia cells 
 
27 
VV 4O10(µ-O)2[VO(H- 
ciprofloxacin)2)]2.13H2O 
 
 
Antibacterial Staphylococus 
aureus, Escherichia 
coli, 
Pseudomonas 
aeruginosa 
 
21 
VV (2-methyl-3H-5-hydroxy-6-
carboxy-4-pyrimidinone ethyl ester) 
 
Antiproliferative 
 
Hela human cervical 
cancer cells 
 
6 
VVO2(salicylaldehydesemicarbazone) 
 
 
Antiproliferative 
 
MC3T3-E1 
osteoblastic mouse 
calvaria-derived 
cells,  
UMR106 rat 
osteosarcoma- 
derived cells  
 
12 
VIVO(3-amino-6(7)-
chloroquinoxaline-2-carbonitrile N1, 
N4-dioxide)2 
 
 
Antiproliferative 
 
V79 chinese hamster 
lung fibroblasts cells 
 
24 
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1.3 Background of nucleolytic activity of metal complexes 
 
Recently, research on nucleolytic activity of metal complexes has blossomed leading to 
the discovery of the capacity of metal complexes to interact with DNA and further to 
induce DNA cleavage in the presence of co-factor. Transition metal complexes such as 
ruthenium, copper, cobalt, manganese and vanadium complexes have been reported to 
promote DNA cleavage in the presence of co-factor [33-55]. The DNA cleavage by 
metal complexes can occur via oxidative, photolytic and hydrolytic cleavage.  
 
Double helical DNA consists of two complementary, antiparallel 
polydeoxyribonucleotide strands associated by specific hydrogen bonding interactions 
between nucleotide bases, Figure 1.2. The backbone of the DNA strand is made from 
alternating phosphate and sugar residues. The sugar in DNA is 2-deoxyribose, which is a 
pentose (five-carbon) sugar. The sugars are joined together by phosphate groups that 
form phosphodiester bonds between the third and fifth carbon atoms of adjacent sugar 
rings. The sugar phosphate backbone of paired strands defines the helical grooves, 
within which the edges of the heterocyclic bases are exposed. The biologically relevant 
B-form structure of the DNA double helix is characterized by a shallow, wide major 
groove and a deep, narrow minor groove. The major and minor grooves provide a lot of 
hydrogen binding sites. The DNA double helix is stabilized by hydrogen bonds between 
the nucleotide bases attached to the two strands. The four bases found in DNA are 
adenine, cytosine, guanine and thymine, Figure 1.3. These four bases are attached to the 
sugar/phosphate to form the complete nucleotide.  
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Figure 1.2: The structure of part of a DNA double helix 
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Figure 1.3: The chemical structure of DNA. Hydrogen bonds are shown as dotted lines 
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The DNA cleavage by metal complexes can be monitored by agarose gel electrophoresis. 
The DNA strain that was used in DNA cleavage studies is pBR322 DNA. The pBR322 
DNA is a double helix DNA and it exists in supercoil form. In general, if scission or 
cleavage occurs on one strand of the supercoil DNA, the supercoil (Form I) will relax 
and convert to nicked form (Form II) while if scission occurs on both strands, a linear 
form (Form III) will be generated (Figure 1.4). These three forms of DNA will migrate 
in different rate in gel electrophoresis (Figure 1.5) with supercoil form migrates the 
fastest while nicked form migrates the slowest and linear form migrates in between 
supercoil and nicked forms. DNA cleavage by metal complexes is varied among the 
complexes, with some metal complexes can induce both single and double strand 
scissions while some metal complexes can only induce single scission.  
 
In oxidative and photolytic DNA cleavage, metal complexes cannot induce DNA 
cleavage directly but indirectly through generating reactive oxygen species (ROS) such 
as hydroxyl radical and singlet oxygen. These ROS are actually responsible in DNA 
cleavage reaction. In order to study the DNA cleavage mechanism by metal complexes, 
various inhibiting agents have been used such as DMSO, t-butanol, mannitol and sodium 
azide. DMSO, t-butanol and mannitol are used as hydroxyl radical inhibitors while 
sodium azide is used as singlet oxygen inhibitor. Meanwhile in hydrolytic DNA 
cleavage, metal complexes can induce DNA cleavage directly by cleaving the P–O 
bonds in the phosphodiester of DNA.  
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Figure 1.4: Supercoiled, nicked and linear DNA 
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Figure 1.5: Supercoiled, nicked and linear DNA bands in gel electrophoresis diagram 
 
 
1.3.1 Oxidative DNA cleavage by metal complexes in the presence of 3-
mercaptopropionic acid (MPA) 
 
Complexes [CuII(ternary-L-glutamine)(1,10-phenanthroline)(H2O)](ClO4) and 
[CuII(ternary-S-methyl-L-cysteine)(1,10-phenanthroline)(H2O)](ClO4) (Figure 1.6) can 
exhibit oxidative DNA cleavage in the presence of 3-mercaptopropionic acid (MPA) [33, 
34]. MPA plays as reduction agent in the DNA cleavage reaction. Both of the complexes 
can only induce single DNA scission by converting supercoil DNA to nicked form. The 
mechanistic aspects of the DNA cleavage reactions have been investigated with various 
inhibiting agents and the results show that hydroxyl radical scavenger DMSO can inhibit 
the DNA cleavage induced by both of the complexes. This indicates the involvement of 
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hydroxyl radical in the cleavage reaction. The proposed DNA cleavage mechanism of 
metal complex in the presence of MPA is illustrated in Figure 1.7.   
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Figure 1.6: The schematic structures;  
                    a) [CuII (ternary-L-glutamine)(1,10-phenanthroline)(H2O)](ClO4) 
                    b) [CuII(ternary-S-methyl-L-cysteine)(1,10-phenanthroline)(H2O)](ClO4) 
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Figure 1.7: The proposed DNA cleavage mechanism of metal complex in the presence    
                    of 3-mercaptopropionic acid (MPA) 
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1.3.2 Oxidative DNA cleavage by metal complexes in the presence of ascorbic acid 
 
Complexes [RuII(imidazo[4,5-f][1,10]phenanthroline)(NH3)4](PF6)2
 and [CuII(L-
threonine)(1,10-phenanthroline)(H2O)](ClO4) (Figure 1.8) can induce oxidative DNA 
cleavage in the presence of ascorbic acid [35, 36]. Similar to MPA, ascorbic acid also 
acts as the reduction agent in the DNA cleavage reaction. Complex [RuII(imidazo[4,5-
f][1,10]phenanthroline)(NH3)4](PF6)2
 can only induce single DNA scission by 
converting supercoil DNA to nicked form while complex [CuII(L-threonine)(1,10-
phenanthroline)(H2O)](ClO4) can induce both single and double DNA scissions by 
converting supercoil DNA to nicked and linear forms. In comparison, complex [CuII(L-
threonine)(1,10-phenanthroline)(H2O)](ClO4) appears to be a better DNA cleaver when 
compared to complex [RuII(imidazo[4,5-f][1,10]phenanthroline)(NH3)4](PF6)2 in the 
presence of ascorbic acid. In mechanistic studies, it is evident that the hydroxyl radical 
scavenger DMSO diminish significantly the nuclease activity of complex [CuII(L-
threonine)(1,10-phenanthroline)(H2O)](ClO4)], which is indicative of the involvement of 
the hydroxyl radical in the cleavage process. The proposed DNA cleavage mechanism of 
metal complex in the presence of ascorbic acid is illustrated in Figure 1.9.   
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      Figure 1.8: The schematic structures;  
                          a) [RuII(imidazo[4,5-f][1,10]phenanthroline)(NH3)4](PF6)2 
                          b) [CuII(L-threonine)(1,10-phenanthroline)(H2O)](ClO4) 
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Figure 1.9: The proposed DNA cleavage mechanism of metal complex in the presence  
                    of ascorbic acid 
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1.3.3 Oxidative DNA cleavage by metal complexes in the presence of H2O2 
 
Complexes [CoII(imidazole-terpyridine)2](ClO4)2 and [Cu
II(imidazole 
terpyridine)2](ClO4)2  (Figure 1.10) can promote oxidative DNA cleavage in the presence 
of H2O2 [37, 38]. In contrast to MPA and ascorbic acid, H2O2 acts as oxidation agent in 
the DNA cleavage reaction. Complex [CoII(imidazole-terpyridine)2](ClO4)2
 can only 
induce single DNA scission by converting supercoil DNA to nicked form while complex 
[CuII(imidazole terpyridine)2](ClO4)2 can induce both single and double DNA scissions 
by converting supercoil DNA to nicked and linear forms. This indicates that the DNA 
cleavage efficiency of complex [CuII(imidazole terpyridine)2](ClO4)2 is higher than the 
DNA cleavage efficiency of complex [CoII(imidazole-terpyridine)2](ClO4)2 in the 
presence of H2O2. From the mechanistic studies, it is shown that the hydroxyl radical 
scavenger DMSO can reduce significantly the nuclease activity of complex 
[CoII(imidazole-terpyridine)2](ClO4)2 while the hydroxyl radical scavenger ethanol can 
reduce significantly the nuclease activity of complex [CuII(imidazole 
terpyridine)2](ClO4)2. This results reflect that the participation of hydroxyl radical in the 
cleavage process. The proposed DNA cleavage mechanism of metal complex in the 
presence of H2O2 is illustrated in Figure 1.11.  
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                Figure 1.10: The schematic structures;  
                                      a) [CoII(imidazole-terpyridine)2](ClO4)2 
                                      b) [CuII(imidazole terpyridine)2](ClO4)2 
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Figure 1.11: The proposed DNA cleavage mechanism of metal complex in the presence  
                      of H2O2 
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1.3.4 Photolytic DNA cleavage by metal complexes  
 
Complexes [CuII(ternary-S-methyl-L-cysteine)(dipyridoquinoxaline)(H2O)](ClO4), [Co
III 
(ethylenediamine)2(imidazo[4,5-f][1,10]-phenanthroline)]Br3, [Ru
II(2,2’-bipyridine)2(5-
methoxy-isatino-[1,2-b]-1,4,8,9-tetraazatriphenylene)](ClO4)2 and [Ni
II(naptho[2,3-a] 
dipyrido[3,2-h:2’,3’-f]phenazine-5,18-dione)(1,10-phenanthroline)](PF6)2 (Figure 1.12) 
can trigger photolytic DNA cleavage upon irradiation [34, 39, 40, 41]. Complexes 
[CuII(ternary-S-methyl-L-cysteine)(dipyridoquinoxaline)(H2O)](ClO4) and [Ru
II(2,2’-
bipyridine)2(5-methoxy-isatino-[1,2-b]-1,4,8,9-tetraaza triphenylene)](ClO4)2 can induce 
both single and double DNA scissions by converting supercoil DNA to nicked and linear 
forms while complexes [CoIII(ethylenediamine)2(imidazo[4,5-f][1,10]-
phenanthroline)]Br3 and [Ni
II(naptho[2,3-a]dipyrido[3,2-h:2’,3’-f]phenazine-5,18-
dione)(1,10-phenanthroline)](PF6)2 can only induce single DNA scission by converting 
supercoil DNA to nicked form. In comparison, DNA cleavage efficiency of complexes 
[RuII(2,2’-bipyridine)2(5-methoxy-isatino-[1,2-b]-1,4,8,9-tetraazatriphenylene)](ClO4)2 
and  [CuII(ternary-S-methyl-L-cysteine)(dipyridoquinoxaline)(H2O)](ClO4) is higher 
than the DNA cleavage efficiency of complexes [CoIII(ethylenediamine)2(imidazo)[4,5-
f][1,10]-phenanthroline)]Br3 and [Ni
II(naptho[2,3-a]dipyrido[3,2-h:2’,3’-f]phenazine-
5,18-dione)(1,10-phenanthroline)](PF6)2 under photolytic DNA cleavage. In mechanistic 
studies, DNA cleavage activity of complexes [RuII(2,2’-bipyridine)2(5-methoxy-isatino-
[1,2-b]-1,4,8,9-tetraazatriphenylene)](ClO4)2 and  [Cu
II(ternary-S-methyl-L-cysteine) 
(dipyridoquinoxaline)(H2O)](ClO4) can be inhibited by singlet oxygen inhibitor sodium 
azide which indicate the contribution of singlet oxygen in the cleavage process. The 
DNA cleavage mechanism of the complexes CoIII(ethylenediamine)2(imidazo[4,5-
 19 
f][1,10]-phenanthroline)]Br3 and [Ni
II(naptho[2,3-a]dipyrido[3,2-h:2’,3’-f]phenazine-
5,18-dione)(1,10-phenanthroline)](PF6)2 is still under investigation. It is proposed that 
photon from the excitation source excites the metal complexes, which then transfers the 
energy to the ground state oxygen molecule (3O2) and excites it to the 
1∆g state (1O2). 
The proposed DNA cleavage mechanism of metal complex under irradiation is 
illustrated in Figure 1.13.  
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Figure1.12: The schematic structures;  
                      a) [CuII(ternary-S-methyl-L-cysteine)(dipyridoquinoxaline)(H2O)](ClO4) 
                      b) [CoIII(ethylenediamine)2(imidazo[4,5-f][1,10]-phenanthroline)]Br3 
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Figure 1.12:  Continued  
                      c) [RuII(2,2’-bipyridine)2(5-methoxy-isatino-[1,2-b]-1,4,8,9-tetraaza   
                          triphenylene)](ClO4)2 
                                d) [Ni
II(naptho[2,3-a]dipyrido[3,2-h:2’,3’-f]phenazine-5,18-dione)(1,10- 
                          phenanthroline)](PF6) 
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Figure 1.13: The proposed DNA cleavage mechanism of metal complex upon 
                               irradiation 
 
 
1.3.5 Hydrolytic DNA cleavage by metal complexes  
 
Cis-aquahydroxo-tetraamine-cobalt(III) complex, [CoIII(bis[2-(2-pyridylethyl)](2-
pyridylmethyl)amine)(OH)(H2O)]
2+, generated from [CoIII(bis[2-(2-pyridylethyl)](2-
pyridylmethyl)amine)(CO3)]ClO4 and complex [Mn
II(quercetin)2(H2O)2]Cl2 (Figure 
1.14) can induce DNA cleavage via hydrolytic pathway [42, 43]. Both of the complexes 
can induce DNA cleavage in the absence of co-factor and in the dark. The mechanistic 
aspects of the DNA cleavage reaction have been investigated with various inhibiting 
agents and the results show that hydroxyl radical and singlet oxygen scavengers cannot 
inhibit the DNA cleavage induced by both of the complexes. These observations indicate 
that hydroxyl radical and singlet oxygen species are not involved in the cleavage 
reaction. The DNA cleavage characteristics of complexes [CoIII(bis[2-(2-pyridylethyl)] 
(2-pyridylmethyl)amine)(OH)(H2O)]
2+ and [MnII(quercetin)2(H2O)2]Cl2 support 
hydrolytic cleavage. Both of the complexes can induce single and double DNA scissions 
by converting supercoil DNA to nicked and linear forms. In hydrolytic cleavage, it is 
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proposed that DNA cleavage occurs at the P–O bond in the phosphodiester of DNA. The 
proposed hydrolytic DNA cleavage mechanism by metal complex is illustrated in Figure 
1.15. 
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Figure 1.14: The schematic structures;  
                    a)  [CoIII(bis[2-(2-pyridylethyl)](2-pyridylmethyl)amine)(OH)(H2O)]
2+ 
                              b) [Mn
II(quercetin)2(H2O)2]Cl2           
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Figure 1.15: The proposed hydrolytic DNA cleavage mechanism by the metal complex 
 
 
1.3.6 Oxidative DNA cleavage by copper(II) amino acid complexes in the presence 
of H2O2 
 
Recently, Ng et al. have demonstrated that neutral CuII amino acid complexes such as 
CuII(N,N-di-(N’-methylacetamido)-L-alaninato)2 and Cu
II(N,N’-dimethylglycinato)2 
(Figure 1.16)  can induce oxidative cleavage of DNA in the presence of H2O2 [44, 45]. 
Both of the complexes can induce single and double DNA scissions by converting 
supercoil DNA to nicked and linear forms. Hydroxyl radical scavenger DMSO can 
inhibit significantly the cleavage reaction induced by complex CuII(N,N’-
 24 
dimethylglycinato)2 which reflect the involvement of hydroxyl radical in cleavage 
reaction. The proposed DNA cleavage mechanism by complex CuII(N,N’-
dimethylglycinato)2  is similar to the proposed DNA cleavage mechanism illustrated in 
Figure 1.11.  
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                      Figure 1.16: The schematic structures; 
                                            a) CuII(N,N’-dimethylglycinato)2                       
                                            b) CuII(N,N-di-(N’-methylacetamido)-L-alaninato)2 
 
